Compounds > pyrenedodecanoylcarnitine
Page last updated: 2024-09-03

pyrenedodecanoylcarnitine and glycolipids

pyrenedodecanoylcarnitine has been researched along with glycolipids in 1 studies

Compound Research Comparison

Studies
(pyrenedodecanoylcarnitine)		Trials
(pyrenedodecanoylcarnitine)		Recent Studies (post-2010)
(pyrenedodecanoylcarnitine)		Studies
(glycolipids)		Trials
(glycolipids)		Recent Studies (post-2010) (glycolipids)
80619,0621705,050

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Calabresi, PA; DeMarino, C; Deme, P; Freed, EO; Haughey, NJ; Kashanchi, F; Rais, R; Slusher, BS; Smith, MD; Tohumeken, S; Waheed, AA; Yoo, SW1

Other Studies

1 other study(ies) available for pyrenedodecanoylcarnitine and glycolipids

ArticleYear
Inhibition of neutral sphingomyelinase 2 impairs HIV-1 envelope formation and substantially delays or eliminates viral rebound.
    Proceedings of the National Academy of Sciences of the United States of America, 2023, 07-11, Volume: 120, Issue:28

    Topics: Animals; Cell Membrane; HIV-1; Mice; Sphingomyelin Phosphodiesterase; Sphingomyelins

2023